<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

Biomarker Discovery

At Crown Bioscience, we are focused on discovering and validating PD, surrogate, and predictive biomarkers that can differentiate between responders and non-responders in a patient population.

Biomarkers of Response: HuMark™

Understand the relationships between genes, protein expression, molecular interactions and activity that define the fundamental components of a predictive biomarkers.

Learn More

 

Biomarker Discovery and Companion Diagnostics

De-risk your therapeutic development through early identification of candidate biomarkers and clinical evaluation of companion diagnostics.

Learn More

 

Mouse Clinical Trials: HuTrial™

Identify responders, partial responders and non-responders with mouse clinical trials to help stratify patients before you enter the clinic.

Learn More

 

Signatures of Response: HuSignature™

Explore a proprietary genetic signature discovery and validation platform, allowing higher identification probability of response to your molecule.

Learn More